Literature DB >> 6582496

Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule.

N Takahashi, T L Ortel, F W Putnam.   

Abstract

We have determined the amino acid sequence of the amino-terminal 67,000-dalton (67-kDa) fragment of human ceruloplasmin and have established overlapping sequences between the 67-kDa and 50-kDa fragments and between the 50-kDa and 19-kDa fragments. The 67-kDa fragment contains 480 amino acid residues and three glucosamine oligosaccharides. These results together with our previous sequence data for the 50-kDa and 19-kDa fragments complete the amino acid sequence of human ceruloplasmin. The polypeptide chain has a total of 1,046 amino acid residues (Mr 120,085) and has attachment sites for four glucosamine oligosaccharides; together these account for the total molecular mass of human ceruloplasmin (132 kDa). The sequence analysis of the peptides overlapping the fragments showed that one additional amino acid, arginine, is present between the 67-kDa and 50-kDa fragments, and another, lysine, is between the 50-kDa and 19-kDa fragments. Only two apparent sites of amino acid interchange have been identified in the polypeptide chain. Both involve a single-point interchange of glycine and lysine that would result in a difference in charge. The results of the complete sequence analysis verified that human ceruloplasmin is composed of a single polypeptide chain and that the subunit-like fragments are produced by proteolytic cleavage during purification (and possibly also in vivo).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6582496      PMCID: PMC344682          DOI: 10.1073/pnas.81.2.390

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Chemical evidence that proteolytic cleavage causes the heterogeneity present in human ceruloplasmin preparations.

Authors:  I B Kingston; B L Kingston; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  Ceruloplasmin. A scavenger of superoxide anion radicals.

Authors:  I M Goldstein; H B Kaplan; H S Edelson; G Weissmann
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

3.  Dissociation and reconstitution of human ceruloplasmin.

Authors:  S Freeman; E Daniel
Journal:  Biochemistry       Date:  1973-11-06       Impact factor: 3.162

4.  Single-chain structure of human ceruloplasmin.

Authors:  L Rydén
Journal:  Eur J Biochem       Date:  1972-04-11

5.  Isolation and partial characterization of the polypeptide chains in human ceruloplasmin.

Authors:  K Simons; A G Bearn
Journal:  Biochim Biophys Acta       Date:  1969-03

6.  Two-dimensional high-performance liquid chromatography and chemical modification in the strategy of sequence analysis. Complete amino acid sequence of the lambda light chain of human immunoglobulin D.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  J Chromatogr       Date:  1983-08-26

7.  Complete amino acid sequence of a 50,000-dalton fragment of human ceruloplasmin.

Authors:  F E Dwulet; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

8.  Purification and characterization of undegraded human ceruloplasmin.

Authors:  M Noyer; F E Dwulet; Y L Hao; F W Putnam
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

9.  Biochemical studies on human ceruloplasmin.

Authors:  M L McCombs; B H Bowman
Journal:  Biochim Biophys Acta       Date:  1976-06-15

10.  Structural studies of asparagine-linked sugar chains of human ceruloplasmin. Structural characteristics of the triantennary complex type sugar chains of human plasma glycoproteins.

Authors:  K Yamashita; C J Liang; S Funakoshi; A Kobata
Journal:  J Biol Chem       Date:  1981-02-10       Impact factor: 5.157

View more
  37 in total

1.  Caeruloplasmin biosynthesis by the human uterus.

Authors:  M L Schilsky; R J Stockert; J W Pollard
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  Ceruloplasmin gene expression in the murine central nervous system.

Authors:  L W Klomp; Z S Farhangrazi; L L Dugan; J D Gitlin
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Reading the molecular clock from the decay of internal symmetry of a gene.

Authors:  P E Gibbs; A Dugaiczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

4.  Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin.

Authors:  W H Kane; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Complete cDNA and derived amino acid sequence of human factor V.

Authors:  R J Jenny; D D Pittman; J J Toole; R W Kriz; R A Aldape; R M Hewick; R J Kaufman; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

6.  Primary structure of cucumber (Cucumis sativus) ascorbate oxidase deduced from cDNA sequence: homology with blue copper proteins and tissue-specific expression.

Authors:  J Ohkawa; N Okada; A Shinmyo; M Takano
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

7.  Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.

Authors:  Z L Harris; Y Takahashi; H Miyajima; M Serizawa; R T MacGillivray; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  Structure of human hemopexin: O-glycosyl and N-glycosyl sites and unusual clustering of tryptophan residues.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.

Authors:  G F Chowrimootoo; H A Ahmed; C A Seymour
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

10.  Intact human ceruloplasmin oxidatively modifies low density lipoprotein.

Authors:  E Ehrenwald; G M Chisolm; P L Fox
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.